💊 Nasdaq-Listed Biotech Firm to Buy $700M in $BNB After ATH Surge

Windtree Therapeutics ($WINT), a Pennsylvania-based biotech company, has announced plans to purchase up to $700 million worth of #BNB , Binance's native cryptocurrency, for its corporate treasury. This comes just one day after BNB hit an all-time high of $808.

🔹 The firm will raise $520M through equity financing, adding to a previously announced $200M commitment.

🔹 It has partnered with Kraken for custody, trading, and OTC services.

🔹 Windtree’s strategy mirrors other public companies diving into crypto treasury holdings, following the lead of Strategy (formerly MicroStrategy).

BNB is currently the 5th largest cryptocurrency with a market cap of $106.9B. Launched in 2017 by Binance, it now powers the #BNBChain , a popular smart contract platform.

Despite a 5% dip today, Windtree's stock is up 162% this month. The move follows similar headlines from Nano Labs, which plans a $1B BNB buy.